Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: Nat Med. 2022 Oct 17;28(11):2424–2435. doi: 10.1038/s41591-022-02023-7

Extended Data Fig. 7. The frequency of defective HIV-1 proviruses.

Extended Data Fig. 7

The frequency of 3’ (a) and 5’ (b) defective HIV-1 proviruses at ART initiation and after 180 and 365 days of ART among individuals in the four groups (lines at median, error bars represent interquartile ranges) (c). P values comparing within group were calculated using paired two-tailed Wilcoxon test. ART only n=14, ART+3BNC117 n=14, ART+RMD n=10, ART+3BNC117+RMD n=14.

ART, antiretroviral therapy; RMD, romidepsin.